Back
RAPT Therapeutics Vs. Emergent BioSolutions Industry Stock Comparison
Sell
30
RAPT
RAPT Therapeutics
Last Price:
8.11
Seasonality Move:
34.14%
Sell
9
EBS
Emergent BioSolutions
Last Price:
3.29
Seasonality Move:
4.47%
Sell
30
RAPT Therapeutics (RAPT)
is a Sell
Is RAPT Therapeutics a Buy, Sell or Hold?
- The current RAPT Therapeutics [RAPT] share price is $8.18. The Score for RAPT is 30, which is 40% below its historic median score of 50, and infers higher risk than normal.
- RAPT is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
9
Emergent BioSolutions (EBS)
is a Sell
Is Emergent BioSolutions a Buy, Sell or Hold?
- The current Emergent BioSolutions [EBS] share price is $1.93. The Score for EBS is 9, which is 82% below its historic median score of 50, and infers higher risk than normal.
- EBS is currently trading in the 0-10% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk could be especially high.
RAPT Stock Price Chart
What is RAPT Therapeutics's stock price today?
-
The RAPT Therapeutics share price today is $8.18
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RAPT is experiencing slight buying pressure.
EBS Stock Price Chart
What is Emergent BioSolutions's stock price today?
-
The Emergent BioSolutions share price today is $1.93
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and EBS is experiencing slight selling pressure.
RAPT Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.48 | Sell |
Relative Strength Index (14 RSI): | 44.57 | Sell |
Chaikin Money Flow: | 61340 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (7.83 - 8.75) | Sell |
Bollinger Bands (100): | (8.12 - 23.6) | Sell |
EBS Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.12 | Sell |
Relative Strength Index (14 RSI): | 41.21 | Sell |
Chaikin Money Flow: | -62150 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (1.94 - 2.34) | Sell |
Bollinger Bands (100): | (1.8 - 2.68) | Sell |
RAPT Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 7.93 | Buy |
20-day SMA: | 8.21 | Sell |
50-day SMA: | 8.51 | Sell |
200-day SMA: | 16.54 | Sell |
8-day EMA: | 7.99 | Buy |
20-day EMA: | 8.25 | Sell |
50-day EMA: | 10.25 | Sell |
200-day EMA: | 15.59 | Sell |
EBS Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 2.03 | Sell |
20-day SMA: | 2.08 | Sell |
50-day SMA: | 2.45 | Sell |
200-day SMA: | 3.05 | Sell |
8-day EMA: | 1.97 | Sell |
20-day EMA: | 2.08 | Sell |
50-day EMA: | 2.22 | Sell |
200-day EMA: | 4.1 | Sell |
RAPT Therapeutics Earnings Growth & RAPT Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.03 per share, an increase next quarter of $0.06 per share, a decrease this year of $0.00 per share, and an increase next year of $0.13 per share.
Emergent BioSolutions Earnings Growth & EBS Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.60 per share, a decrease next quarter of $0.00 per share, an increase this year of $2.88 per share, and an increase next year of $0.85 per share.
RAPT Therapeutics Technical Analysis
Apr 18 | Apr 19 | Apr 22 | Apr 23 | Apr 24 | Apr 25 | Apr 26 | Apr 29 | Apr 30 | May 1 | |
---|---|---|---|---|---|---|---|---|---|---|
Apr | ||||||||||
18 | 19 | 22 | 23 | 24 | 25 | 26 | 29 | 30 | 01 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Emergent BioSolutions Technical Analysis
Apr 18 | Apr 19 | Apr 22 | Apr 23 | Apr 24 | Apr 25 | Apr 26 | Apr 29 | Apr 30 | May 1 | |
---|---|---|---|---|---|---|---|---|---|---|
Apr | ||||||||||
18 | 19 | 22 | 23 | 24 | 25 | 26 | 29 | 30 | 01 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |